Cite
APA Citation
Diamantopoulos, P. T., Stafylidis, C., Vlachopoulou, D., Kontandreopoulou, C., Giannakopoulou, N., Vardaka, M., Mpouhla, A., Mastrogianni, E., Variami, E., Galanopoulos, A., Pappa, V., Psichogiou, M., Hatzakis, A., & Viniou, N. (2022). safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study. Therapeutic advances in hematology, 13, . http://access.bl.uk/ark:/81055/vdc_100169883711.0x000045